Kataria BC. Lorcaserin: a selective serotonin receptor (5-HT2C) agonist for the treatment of obesity. Int J Basic Clin Pharmacol [Internet]. 2017 Feb. 3 [cited 2023 May 31];1(1):45-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1398